PLAUR and colorectal carcinoma: uPAR overexpression, on the other hand, is associated with various types of cancers [83], and therefore has been proposed as a potential prognostic marker to delineate the II and III substages of CRC-II in an attempt to resolve the contradictions between earlier antibody-based studies [84, 85].